Aimmune reveals data from its ARC002 Phase 2 trial
Aimmune Therapeutics Inc. recently revealed data from the open-label ARC002 Phase 2 trial for its product, AR101, designed to treat peanut allergies. Read More »
Aimmune Therapeutics Inc. recently revealed data from the open-label ARC002 Phase 2 trial for its product, AR101, designed to treat peanut allergies. Read More »
The top 15 pharmacies of 2015, ranked by total U.S. prescription dispensing revenues, are largely central-fill, mail and specialty pharmacies, according to a recent article released by the Drug Channels Institute. Read More »
Amgen announced earlier this week that it has submitted to the U.S. Food and Drug Administration (FDA) a supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) that will include new information to support the treatment of pediatric and adolescent patients who have been diagnosed with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Read More »
McKesson Corp. announced this week that it has agreed to terms to buy Vantage Oncology LLC and Biologics Inc. Read More »
PrescribeWellness and SinfoniaRx have announced that the two companies have signed an agreement that will allow for the optimization of medical treatments for millions of patients nationwide. Read More »
RelayHealth Financial announced last week a comprehensive agenda for the HIMSS16 Conference and Exhibition that will aid financial leaders in the health care industry to hurdle obstacles that disturb payments when the financial and clinical processes are not interconnected. Read More »
Amgen and UCB announced this week positive results from the Phase 3 trial of a fracture study in postmenopausal women with osteoporosis (FRAME). Read More »
McKesson announced this week that it has renewed health care IT services with Saint Anthony Hospital, based in Chicago, Illinois, and Cookeville Regional Medical Center (CRMC), located in Tennessee. Read More »
McKesson Specialty Health announced this week that the Scottsdale Area Chamber of Commerce has awarded its Reimbursement, Access & Services Solution Center the Sterling Award. Read More »
Amgen announced this week that the Phase 3 Aranesp (darbepoetin alfa) ARCADE trial succeeded in reducing the occurrence of red blood cell transfusions for patients with low and intermediate-1 risk Myelodysplastic Syndrome (MDS) who are also anemic. Read More »
BodyMcKesson announced this week that KLAS, an independent health research firm, has named McKesson Labs 2015/2016 Best in KLAS for Laboratory. Read More »
US Oncology Research announced recently that it has found and recruited its 2,000th patient to take part in a Phase I clinical trial through its Translational Oncology Program (TOP). Read More »
Verseon Corp. announced this week that it plans on unveiling new pre-clinical results in the form of a poster that will feature brand-new data for oral anticoagulant drug candidates currently in development. Read More »
Lafayette Radiology, a radiology group based in Lafayette, Indiana, announced last week that will begin utilizing McKesson Business Performance Services in order to help its staff adjust to ICD-10. Read More »
Livanta announced last week that it has agreed to the long-term use of InterQual to ensure and review the quality of care for Medicare beneficiaries, including short-stay patients. Read More »
ACADIA Pharmaceuticals announced last week that the Psychopharmacologic Drugs Advisory Committee, a committee that operates under the FDA, will review its New Drug Application (NDA) for NUPLAZID. Read More »
Keystone Peer Review Organization Inc. (KEPRO) announced this week that it has agreed to its continued use of InterQual on a long-term basis. Read More »
McKesson Pharmacy Systems & Automation (MPS&A) has announced the release of its new technological platform, the McKesson Clinical Programs Solution, which is designed to help pharmacists tailor wellness plans to patients with specific needs. Read More »
ACADIA Pharmaceuticals said on Monday that it has hired Dr. James "Randy" Owen to be its new senior vice president for clinical development and chief medical officer. Read More »
McKesson Health Solutions has introduced two solutions to help expedite the payment process. Read More »